[1] Liu YH,Di YM,Zhou ZW,et al.Multidrug resistance-associated proteins and implications in drug development[J].Clin Exp Pharmacol Physiol,2010,37(1):115-120.
[2] Rau S,Autschbach F,Riedel HD,et al.Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas[J].Eur J Clin Invest,2008,38(2):134-142.
[3] Jiang H,Chen K,He J,et al.Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance[J].J Gastrointest Surg,2009,13(10):1831-1838.
[4] Lindor KD,Kowdley KV,Luketic VA,et al.High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis[J].Hepatology,2009,50(3):808-814.
[5] 张艳梅,柴进,陈文生,等.芒果苷上调HepG2细胞膜蛋白MRP3和核受体PXR、CPF表达[J].第三军医大学学报,2011,33(3):246-249.
[6] Carlton VE,Pawlikowska L,Bull LN.Molecular basis of intrahepatic cholestasis4[J].Ann Med,2004,36(8):606-617.
[7] Bohan A,Chen WS,Denson LA,et al.Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis[J].J Biol Chem,2003,278(38):36688-36698.
[8] Scheffer GL,Kool M,Scheper RJ,et al.Tissue distribution and induction of human multidrug resistant protein 3[J].Lab Invest,2002,82(2):193-201.
[9] Hasegawa Y,Kishimoto S,Takahashi H,et al.Altered expression of MRP2,MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis[J].J Pharm Pharmacol,2009,61(9):1205-1210.
[10] Csanaky IL,Aleksunes LM,Tanaka Y,et al.Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice[J].Am J Physiol Gastrointest Liver Physiol,2009,297(3):G419-G433.
[11] Halibasic E,Claudel T,Trauner M.Bile acid transporters and regulatory nuclear receptors in the liver and beyond[J].J Hepatol,2013,58(1):155-168.
[12] Chan J,Chen WS,Boyer JL,et al.Elevated hepatic MRP3/ABCC3 expression in human obstructive cholestasis is mediated through TNF-α and JNK/SAPK signaling pathway[J].Hepatology,2012,55(5):1485-1494.
[13] Wagner M,Zollner G,Trauner M,et al.New molecular insights into the mechanisms of cholestasis[J].J Hepatol,2009,51(3):565-580.
[14] 李琼,陈文生,罗东林,等.阻塞性胆汁淤积大鼠肝细胞膜蛋白MRP3与核受体RXRα蛋白表达关系的研究[J].第三军医大学学报,2006,28(12):1298-1300.
[15] He J,Nishida S,Xu M,et al.PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts[J].Gastroenterology,2011,140(7):2095-2106.
[16] Kliewer SA,Moore JT,Wade L,et al.An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway[J].Cell,1998,92(1):73-82.
[17] Teng S,Piquette-Miller M.Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis[J].Brit J Pharmacol,2007,151(3):367-376.
[18] Harmsen S,Meijerman I,Beijnen JH,et al.Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs:a key role for the pregnane X receptor[J].Cancer Chemoth Pharm,2009,64(1):35-43.
[19] Luckert C,Ehlers A,Buhrke T,et al.Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR[J].Toxicol Lett,2013,222(2):180-188.